Home / Inspections / 1243223

FDA Inspection 1243223 — Novocol Pharmaceutical of Canada, Inc.

Novocol Pharmaceutical of Canada, Inc. — FEI 3002807757

The FDA completed an inspection of Novocol Pharmaceutical of Canada, Inc. on May 3, 2024 in Cambridge. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 3, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cambridge (Canada)

Facility

Other inspections at this facility

  • 1117454 (NAI Thu Jan 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1098218 (NAI Fri Jun 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1093310 (VAI Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1019963 (VAI Wed Jul 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1012538 (VAI Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources